药品的强制许可制度及在TRIPS-PLUS协定下对我国药品知识产权制度的影响

发布时间：2018-04-04 09:05

本文选题：TRIPS-PLUS　切入点：药品专利强制许可　出处：《复旦大学》2011年硕士论文

【摘要】：药品专利的强制许可是一个世界性的问题,我国也不断关注并完善药品专利的强制许可制度。建立强制许可制度目的在于防止专利权人滥用专利权来阻碍创新和损害公共利益,及平衡公共利益与个人利益之间的关系。随着各国特别是发展中国家对强制许可制度的重视和积极实施,美国和欧盟等国家将注意力转到了在双边自由贸易中通过增加TRIPS-PLUS条款来限制强制许可的使用。它们与有关国家签订了含有TRIPS-PLUS条款的双边或多边自由贸易协定,迫使部分发展中国家无形中就提高了本国知识产权保护水平。论文分别介绍了药品专利的强制许可、TRIPS-PLUS协议和药品的可及性的概念,总结了药品专利强制许可制度对药品可及性的影响,剖析了TRIPS-PLUS产生的背景,随后分析在wTO背景下TRIPS协议第31条、《多哈宣言》、《总理事会协议》和《TRIPS协议修正案》的内容及影响。其次阐述TRIPS-PLUS协议的含义、内容,指出自由贸易协定中的TRIPS-PLUS协议对药品专利强制许可的影响,通过分析美国与约旦、中美洲国家以及澳大利亚等国签订自由贸易协议中所含有的TRIPS-PLUS条款对药品的强制许可和政府使用的影响,指出我国作为大量依靠仿制药品的发展中国家,根据我国目前的公共健康现状,结合我国目前强制许可现状,分析在国内立法及签署自由贸易区协定等国际条约时,必须注意不要盲目地签订含有TRIPS-PLUS条款的协议,审慎引入专利链接制度,为数据独占保护设置限制条件,保留强制许可、平行进口等TRIPS协议允许的弹性条款,使保护标准与我国现阶段的发展相适应。
[Abstract]:The drug patent compulsory license is a major problem in the world, our country has been concern and improve the drug patent compulsory license system. The establishment of compulsory licensing system to prevent the patentee to impede innovation and harm the public interest, and the relationship between the balance of public interests and individual interests.
As countries especially developing countries for compulsory licensing of attention and actively implemented, the United States and the European Union and other countries will be attention to in bilateral free trade by increasing the TRIPS-PLUS terms to limit the compulsory license. They signed with TRIPS-PLUS in terms of bilateral or multilateral free trade agreements with other countries, forcing some developing countries virtually increased their level of intellectual property protection.
This paper introduced the compulsory license for drug patents, TRIPS-PLUS protocol and drug accessibility concept, summarizes the drug patent compulsory license system on drug accessibility effects, analyzes the background of TRIPS-PLUS, then analysis on the background of wTO protocol of TRIPS thirty-first, "Doha declaration", "the content and effect of total the protocol and

>. Secondly, the TRIPS-PLUS protocol content, meaning that in free trade agreement TRIPS-PLUS agreement effect on drug patent compulsory license, through the analysis of the United States and Jordan, in America and Australia and other countries signed TRIPS-PLUS terms contained in the free trade agreement for drug enforcement the license and government use, pointed out that China is relying heavily on generic drugs in developing countries, according to the current situation of public health in China, combined with China's current compulsory License status analysis in domestic legislation and signed a free trade agreement and other international treaties, must be careful not to sign the agreement with TRIPS-PLUS blindly, careful introduction of patent link system, exclusive protection restrictions for data retention, compulsory license, the elastic clause of parallel import TRIPS protocol allowed, the standards of protection and development in the present stage of our country to adapt.

【学位授予单位】：复旦大学
【学位级别】：硕士
【学位授予年份】：2011
【分类号】：D923.42;D997.1

【参考文献】